Gyre Therapeutics, Inc. (GYRE) ownership: Top institutional holder: VANGUARD GROUP INC ($8.48M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 1201589.00 | $8.48M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 984204.00 | $6.86M | 2026-03-31 |
| BlackRock, Inc. | 758630.00 | $5.29M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 431414.00 | $3.01M | 2026-03-31 |
| STATE STREET CORP | 216326.00 | $1.51M | 2026-03-31 |
| SBI Securities Co., Ltd. | 170837.00 | $1.19M | 2026-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 165238.00 | $1.15M | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 137682.00 | $959644.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-06-08 |
Back to GYRE overview · GYRE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.